K (2000-2009)

KIDNEYS


KIDNEYS
‘Entourage’ effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism (full–2002) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573364/
Cream with endocannabinoids effective in the treatment of pruritus due to kidney disease (news-2005) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=207
Modulation of P-glycoprotein activity by cannabinoid molecules in HK-2 renal cells (full-2006) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1751877&tool=pmcentrez
Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor (full–2006) http://molpharm.aspetjournals.org/content/70/1/41.long
Differential mechanisms mediating depressor and diuretic effects of anandamide (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/17053550
Regulation of Bone Mass, Osteoclast Function, and Ovariectomy-Induced Bone Loss by the Type 2 Cannabinoid Receptor (full–2008) http://press.endocrine.org/doi/full/10.1210/en.2008-0150
The preventive effect of cannabinoids on reperfusion-induced ischemia of mouse kidney (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/18571910
Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A4 (full–2009) http://www.fasebj.org/cgi/content/full/23/5/1503?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabis&searchid=1&FIRSTINDEX=2400&resourcetype=HWCIT
The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation (full-2009) http://www.fasebj.org/content/23/1/183.long
Rimonabant affects cyclosporine a, but not tacrolimus pharmacokinetics in renal transplant recipients (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19384170


Advertisements